Human apolipoprotein E isoprotein subclasses are genetically determined.

In a recent communication, we showed that human very low density lipoprotein (VLDL) apolipoprotein E (Apo E) from different individuals appears upon two-dimensional gel electrophoretic analysis in either one of two complex patterns. These have been designated class alpha and class beta. Mixing of VLDL from different subjects revealed that not all alpha or beta apo E patterns were the same. In this manner, we identified three subclasses of class alpha (alpha II, alpha III, and alpha IV) and three subclasses of class beta (beta II, beta III, and beta IV). We report here the results of family studies that reveal that the subclasses (alpha II, alph III, and alpha IV and beta II, beta III, and beta IV) of apo E are determined at a single genetic locus with three common alleles, epsilon II, epsilon III, and epsilon IV. The class beta phenotypes (beta II, beta III, and beta IV) represent homozygosity for two identical apo E alleles (epsilon). In contrast, class alpha phenotypes (alpha II, alpha III, and alpha IV) represent heterozygosity for two different apo E alleles. The apo E subclasses and their corresponding genotypes are as follows: beta II = epsilon II/epsilon II; beta III = epsilon III; beta IV = epsilon IV/epsilon IV; alpha II = epsilon II/epsilon III; alpha III = epsilon III/epsilon IV; and alpha IV = epsilon II/epsilon IV. To estimate the frequencies of the apo E alleles in the general population, apo E subclasses were then investigated in 61 unrelated volunteers and the results were: beta II = 1 (2%), beta III = 30 (49%), alpha II = 9 (15%, alpha III = 13 (31%), and alpha IV = 2 (3%). Utilizing the frequencies of these phenotypes, the gene frequencies were calculated to be epsilon II = 11%, epsilon III = 72%, and epsilon IV = 17%. In addition, apo E subclasses were studied in a clinic for individuals with plasma lipid disorders and the apo E subclass beta IV was found to be associated with type III hyperlipoproteinemia. There was no association of any apo E subclass with type II, type IV, or type VI hyperlipoproteinemia or plasma HDL cholesterol levels. This study explains the genetic basis for the common variation in a human plasma protein, apo E. Since the apo E subclass beta IV is associated with type III hyperlipoproteinemia, a disease characterized by xanthomatosis and premature atherosclerosis, understanding the genetic basis of the apo E subclasses should provide insight into the genetics of type III hyperlipoproteinemia.

[1]  D. B. Zilversmit.  Atherogenesis: a postprandial phenomenon. , 1979, Circulation.

[2]  L. Dory,et al.  Secretion of cholesterol-rich lipoproteins by perfused livers of hypercholesterolemic rats. , 1979, The Journal of clinical investigation.

[3]  G. Utermann,et al.  Different mobility in SDS—polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes Apo E‐N and Apo E‐D , 1979, FEBS letters.

[4]  B. Suarez,et al.  Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. , 1979, The Journal of laboratory and clinical medicine.

[5]  J. Medalie,et al.  High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. , 1979, American journal of epidemiology.

[6]  B. Bulkley,et al.  The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. , 1979, American journal of epidemiology.

[7]  R. Mahley,et al.  Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. , 1978, The Journal of biological chemistry.

[8]  W. Hazzard,et al.  High-density lipoproteins in myocardial infarction survivors. , 1978, Metabolism: clinical and experimental.

[9]  W. Hazzard,et al.  Catabolism of very low density lipoproteins in the rabbit. Effect of changing composition and pool size. , 1978, Biochimica et biophysica acta.

[10]  P. Wahl,et al.  Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay. , 1977, Annals of internal medicine.

[11]  G. Utermann,et al.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man , 1977, Nature.

[12]  W. Kannel,et al.  Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. , 1977, Annals of internal medicine.

[13]  R. Havel,et al.  Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. , 1977, Journal of lipid research.

[14]  M C Hjortland,et al.  Predicting coronary heart disease in middle-aged and older persons. The Framington study. , 1977, JAMA.

[15]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[16]  R. Mahley,et al.  Alterations of the plasma lipoproteins and apoproteins following cholesterol feeding in the rat. , 1977, Journal of lipid research.

[17]  J. Breslow,et al.  Lipoprotein regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in rat liver cell cultures. , 1977, The Journal of biological chemistry.

[18]  P. Alaupovic,et al.  Determination of human apolipoprotein E by electroimmunoassay. , 1976, Biochimica et biophysica acta.

[19]  R. Mahley,et al.  Atherogenic hyperlipoproteinemia induced by cholesterol feeding the Patas monkey. , 1976, Biochemistry.

[20]  T. Koschinsky,et al.  A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESS , 1976, The Lancet.

[21]  R. Mahley,et al.  Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. , 1975, Biochemistry.

[22]  P. O’Farrell.  High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[23]  R. Levy,et al.  Type III hyperlipoproteinemia: an analysis of two contemporary definitions. , 1975, Annals of internal medicine.

[24]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[25]  S. Quarfordt,et al.  A new apoprotein of human plasma very low density lipoproteins. , 1974, The Journal of biological chemistry.

[26]  F. Studier,et al.  Analysis of bacteriophage T7 early RNAs and proteins on slab gels. , 1973, Journal of molecular biology.

[27]  R. Havel,et al.  Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[28]  V. Shore,et al.  Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. , 1973, Biochemistry.

[29]  D. Porte,et al.  Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia). , 1972, Metabolism: clinical and experimental.

[30]  S. Quarfordt,et al.  The carbohydrate content of apolipoprotein E from human very low density lipoproteins. , 1979, Life sciences.

[31]  C. Sirtori,et al.  Very low density lipoproteins in normal and cholesterol-fed rabbits: lipid and protein composition and metabolism. Part 1. Chemical composition of very low density lipoproteins in rabbits. , 1976, Atherosclerosis.

[32]  G. Utermann,et al.  Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteins , 1975, FEBS letters.

[33]  M. Mishkel,et al.  A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinaemia. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[34]  M. Marion.  The Familial Hyperlipoproteinemias , 1975 .